关键数据
0.519今开
0.519最高
364.90K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.89%换手率
0.517昨收
0.493最低
133.58K成交额
亏损市盈率静
32.43市净率
0.00%股息率 TTM
-310.39%ROA
4.00052周最高
1.33量比
-19.45M净利润
41.13M总股本
-0.5587每股收益TTM
-0.86Beta
-495.61%ROE
0.54052周最低
5.10%振幅
--毛利率
20.59M总市值
-3.86回报/风险
7.30%风险率
Heartbeam Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Edwards Lifesciences Corp
EW
33
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Heartbeam Inc简介
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
公司代码BEAT
公司Heartbeam Inc
CEOEno (Robert P)
网址https://www.heartbeam.com/
公司股东
常见问题
Heartbeam Inc(BEAT)的当前股价是多少?
Heartbeam Inc(BEAT)的当前股价是 0.50。
Heartbeam Inc股票的52周最高点是多少?
Heartbeam Inc股票的52周最高点是4.00。
Heartbeam Inc股票的52周最低点是多少?
Heartbeam Inc股票的52周最低点是0.54。
现在Heartbeam Inc(BEAT)的股票是买入、持有还是卖出?
根据分析师评级,Heartbeam Inc(BEAT)的总体评级为买入,目标价格为3.38。
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.62。